These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11038688)

  • 1. [Engineering antibody: from laboratory to clinic].
    Xiao C; Zhu X
    Sheng Li Ke Xue Jin Zhan; 1997 Oct; 28(4):341-4. PubMed ID: 11038688
    [No Abstract]   [Full Text] [Related]  

  • 2. Bispecific antibodies: molecules that enable novel therapeutic strategies.
    Fischer N; Léger O
    Pathobiology; 2007; 74(1):3-14. PubMed ID: 17496428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bivalent monoclonal IgY antibody formats by conversion of recombinant antibody fragments.
    Greunke K; Spillner E; Braren I; Seismann H; Kainz S; Hahn U; Grunwald T; Bredehorst R
    J Biotechnol; 2006 Jul; 124(2):446-56. PubMed ID: 16490273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to Ivarie: Competitive bioreactor hens on the horizon.
    Etches RJ
    Trends Biotechnol; 2006 Mar; 24(3):101-2. PubMed ID: 16448712
    [No Abstract]   [Full Text] [Related]  

  • 5. Expression and purification of monospecific and bispecific recombinant antibody fragments derived from antibodies that block the CD80/CD86-CD28 costimulatory pathway.
    Dincq S; Bosman F; Buyse MA; Degrieck R; Celis L; de Boer M; Van Doorsselaere V; Sablon E
    Protein Expr Purif; 2001 Jun; 22(1):11-24. PubMed ID: 11388794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of target-specific recombinant human polyclonal antibodies in mammalian cells.
    Wiberg FC; Rasmussen SK; Frandsen TP; Rasmussen LK; Tengbjerg K; Coljee VW; Sharon J; Yang CY; Bregenholt S; Nielsen LS; Haurum JS; Tolstrup AB
    Biotechnol Bioeng; 2006 Jun; 94(2):396-405. PubMed ID: 16596663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant bispecific antibodies for cellular cancer immunotherapy.
    Müller D; Kontermann RE
    Curr Opin Mol Ther; 2007 Aug; 9(4):319-26. PubMed ID: 17694444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant bispecific antibodies for cancer therapy.
    Kontermann RE
    Acta Pharmacol Sin; 2005 Jan; 26(1):1-9. PubMed ID: 15659107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Competitive bioreactor hens on the horizon.
    Ivarie R
    Trends Biotechnol; 2006 Mar; 24(3):99-101. PubMed ID: 16445998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical engineering.
    Carrondo MJ; Aunins JG
    Curr Opin Biotechnol; 2004 Oct; 15(5):441-3. PubMed ID: 15464375
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunologically driven chemical engineering of antibodies for catalytic activity.
    Dias S; Jovic F; Renard PY; Taran F; Créminon C; Mioskowski C; Grassi J
    J Immunol Methods; 2002 Nov; 269(1-2):81-98. PubMed ID: 12379354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catalytic antibodies (abzymes) induced by stable transition-state analogs.
    Nevinsky GA; Semenov DV; Buneva VN
    Biochemistry (Mosc); 2000 Nov; 65(11):1233-44. PubMed ID: 11112839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ['New look' biotechnology].
    de Voogd van der Straaten WA
    Tijdschr Diergeneeskd; 1987 Jan; 112(1):3-8. PubMed ID: 3469783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IBC sixth annual meeting on antibody engineering Dec 4-6 1995, La Jolla, CA.
    Metz C
    Mol Med; 1996 Mar; 2(2):169-70. PubMed ID: 8726459
    [No Abstract]   [Full Text] [Related]  

  • 15. Catumaxomab, a rat/murine hybrid trifunctional bispecific monoclonal antibody for the treatment of cancer.
    Shen J; Zhu Z
    Curr Opin Mol Ther; 2008 Jun; 10(3):273-84. PubMed ID: 18535935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant approaches to IgG-like bispecific antibodies.
    Marvin JS; Zhu Z
    Acta Pharmacol Sin; 2005 Jun; 26(6):649-58. PubMed ID: 15916729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multivalency: the hallmark of antibodies used for optimization of tumor targeting by design.
    Deyev SM; Lebedenko EN
    Bioessays; 2008 Sep; 30(9):904-18. PubMed ID: 18693269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The assembly of single domain antibodies into bispecific decavalent molecules.
    Stone E; Hirama T; Tanha J; Tong-Sevinc H; Li S; MacKenzie CR; Zhang J
    J Immunol Methods; 2007 Jan; 318(1-2):88-94. PubMed ID: 17141798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Display of a functional hetero-oligomeric catalytic antibody on the yeast cell surface.
    Lin Y; Tsumuraya T; Wakabayashi T; Shiraga S; Fujii I; Kondo A; Ueda M
    Appl Microbiol Biotechnol; 2003 Aug; 62(2-3):226-32. PubMed ID: 12883868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering mammalian cell factories for improved recombinant monoclonal antibody production: lessons from nature?
    Dinnis DM; James DC
    Biotechnol Bioeng; 2005 Jul; 91(2):180-9. PubMed ID: 15880827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.